FDAnews
www.fdanews.com/articles/97065-hillenbrand-narrows-guidance-after-charges-impact-results

Hillenbrand Narrows Guidance After Charges Impact Results

August 10, 2007

Litigation expenses, a terminated acquisition deal and costs related to its separation into two companies had a negative impact on Hillenbrand Industries Inc.’s third-quarter earnings, and its stock price.
Business Courier